Medicover AB (LTS:0RPS) 5-Year Yield-on-Cost %: 0.99 (As of Jul. 24, 2026) — 36% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RPS Medicover AB LTS:0RPS
89 GF Score
Price kr217.50
GF Value kr229.81
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Medicover AB 5-Year Yield-on-Cost %?

Medicover AB LTS:0RPS -3.97% 89 5-Year Yield-on-Cost % is 0.99 as of Jul. 24, 2026, which is 36% above its 10-year median of 0.73. GuruFocus rates LTS:0RPS with a GF Score™ of 89/100 and a GF Value™ of kr229.81 (Fairly Valued). The stock has 5 warning signs investors should review. Among 277 Healthcare Providers & Services companies, Medicover AB ranks worse than 78.34% on this metric.

Medicover AB's yield on cost for the quarter that ended in Jun. 2026 was 0.99.


The historical rank and industry rank for Medicover AB's 5-Year Yield-on-Cost % or its related term are showing as below:

LTS:0RPS' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.19   Med: 0.73   Max: 1.15
Current: 0.99


During the past 12 years, Medicover AB's highest Yield on Cost was 1.15. The lowest was 0.19. And the median was 0.73.


LTS:0RPS's 5-Year Yield-on-Cost % is ranked worse than
78.34% of 277 companies
in the Healthcare Providers & Services industry
Industry Median: 2.9 vs LTS:0RPS: 0.99

Medicover AB  (LTS:0RPS) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Medicover AB 5-Year Yield-on-Cost % Related Terms


LTS:0RPS vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison

For the Medical Care Facilities subindustry, Medicover AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicover AB 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Medicover AB's 5-Year Yield-on-Cost % falls into.


LTS:0RPS
89GF Score
Medicover AB LTS:0RPS
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicover AB 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Medicover AB is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.99 mean?
Medicover AB (LTS:0RPS) has a 5-Year Yield-on-Cost % of 0.99 as of Jul. 24, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medicover AB and its competitors. This is 36% above median its historical median of 0.73. Over the past decade, Medicover AB's 5-Year Yield-on-Cost % has ranged from 0.19 to 1.15. According to the industry distribution chart, Medicover AB ranks #217 out of 277 companies in the Healthcare Providers & Services industry, placing it in the top 78.3%.
Is Medicover AB's 5-Year Yield-on-Cost % too high?
Medicover AB's current 5-Year Yield-on-Cost % of 0.99 is 36% above median its 10-year median of 0.73. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 1.15. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.90. Medicover AB's value of 0.99 is 65.9% below this industry median. Based on the distribution chart, Medicover AB ranks #217 out of 277 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Medicover AB has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicover AB ranks #217 out of 277 companies for 5-Year Yield-on-Cost %. This places Medicover AB in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.90. Medicover AB's value of 0.99 is 65.9% below this benchmark. Historically, Medicover AB's own 5-Year Yield-on-Cost % has ranged from 0.19 to 1.15 over the past decade. While the company's 10-year median is 0.73 vs. the industry median of 2.90, Medicover AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.90, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicover AB's current 5-Year Yield-on-Cost % of 0.99 is 65.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medicover AB and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicover AB's current 5-Year Yield-on-Cost % is 0.99, which is 36% above median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr229.81, compared to a current price of kr217.50 — trading 5.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.99, which is 36% above median its 10-year median of 0.73 and 65.9% below the Healthcare Providers & Services industry median of 2.90. Medicover AB's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current 5-Year Yield-on-Cost % is 0.99 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicover AB (LTS:0RPS) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be undervalued. The current stock price of kr217.50 is trading 5.4% below its estimated GF Value™ of kr229.81. GuruFocus considers Medicover AB to be Fairly Valued.

Key valuation signals for LTS:0RPS:

  • 5-Year Yield-on-Cost %: 0.99 (36% above median its 10-year median of 0.73)
  • GF Value™: kr229.81 vs. price of kr217.50 (5.4% below fair value)
  • GF Score™: 89/100 with 5 warning signs
  • Industry Position: 65.9% below the Healthcare Providers & Services median (#217 of 277)

No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
89GF Score

Get the complete analysis for LTS:0RPS

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr217.50
Price
kr229.81
GF Value